Delivery Order SPE2DR25D3019-SPE2DR26FK4BA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of EUCRISA 2% Ointment in 60-gram units under a firm fixed-price contract with a ceiling value of $4,106.07. The award was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,788.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of EUCRISA 2% ointment, a prescription medication, with a period of performance through August 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the procurement of a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of EUCRISA 2% ointment in 60 gram quantities. The $2,555.05 firm fixed-price delivery order contract is non-set-aside and was awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain. The contract has an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,152.59 firm fixed-price delivery order is for the supply of EUCRISA 2% ointment, a topical medication, with a performance period ending on May 20, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,790.85 to AmerisourceBergen Drug Corp for EUCRISA 2% Ointment (60 gm) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. EUCRISA is a topical calcineurin inhibitor commonly used to treat atopic dermatitis and other inflammatory skin...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,372.25, is for the delivery of EUCRISA 2% Ointment 60GM, a pharmaceutical product. The contract is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,545.62 to supply Eucrisa 2% Ointment in 100-gram quantities. This non-competitive, competitively awarded delivery order represents a firm fixed price contract with an ultimate completion date of June 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child order issued under a larger Indefinite Delivery Contract vehicle. This...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,808.20 firm-fixed-price contract is for the supply of EUCRISA 2% ointment, a pharmaceutical product, with an ultimate completion date of August 17, 2023. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this award. The company is a major supplier of pharmaceutical products and medical supplies to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of EUCRISA 2% ointment (60 gram tubes), a topical treatment for a skin condition. The contract has a ceiling value of $1,216.56 and a completion date of January 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, with an ID of SPE2DX15D7056|SPE2DX24F1UDE, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation for the delivery of EUCRISA 2% ointment in 60 gram tubes. The firm fixed price delivery order has a ceiling value of $1,341.26 and an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, is the prime...
- SPE2DR25D3019Indefinite Delivery Contract
- SPE2DR25D3019-SPE2DR26FK4BADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,776.79 on November 13, 2025, for EUCRISA 2% Ointment in 60-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill this medical supply need. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and extending through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The contract supports critical medical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/13/25 |